DENALI THERAPEUTICS INC (DNLI:NASDAQ)
$19.73 0.5 (2.6001%)
Analysed DENALI THERAPEUTICS INC (DNLI:NASDAQ) News Sources
A Look At Takeda Pharmaceutical (TSE:4502) Valuation After Mixed Pipeline News On DNL593 And Zasocitinib
08-04-2026
yahoo.com
Denali Stock Falls as Partner Takeda Ends Collaboration Deal
07-04-2026
yahoo.com
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
03-04-2026
yahoo.com
Denali Solved A Major Challenge In Treating A Rare Genetic Disease. Now, Shares Are Flying.
01-04-2026
yahoo.com
Denali Therapeutics (DNLI) Is Down 13.9% After First BBB-Crossing Hunter Therapy Wins FDA Nod - What's Changed
30-03-2026
yahoo.com
Denali Wins FDA Nod for Hunter Syndrome Drug, Stock Up
26-03-2026
yahoo.com
Denali Therapeutics Wins FDA Accelerated Approval for AVLAYAH in Hunter Syndrome, Eyes Launch Boost
25-03-2026
marketbeat.com
Denali Jumps, Pulling Regenxbio Higher, On Early FDA Approval
25-03-2026
yahoo.com
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)
25-03-2026
yahoo.com
Denali Therapeutics CEO: 2026 Pivotal With Hunter Syndrome FDA Decision and New TV Trial Readouts
19-03-2026
marketbeat.com
What is the current price of DENALI THERAPEUTICS INC (DNLI:NASDAQ)?
The current price of DENALI THERAPEUTICS INC (DNLI:NASDAQ) is $19.73.
DENALI THERAPEUTICS INC (DNLI:NASDAQ) absolute price change since previous trading day?
The absolute price change of DENALI THERAPEUTICS INC (DNLI:NASDAQ) since the previous trading day is $0.5.
DENALI THERAPEUTICS INC (DNLI:NASDAQ) percentage price change since previous trading day?
The percentage price change of DENALI THERAPEUTICS INC (DNLI:NASDAQ) since the previous trading day is 2.6001%.
What is the most recent average sentiment score for DENALI THERAPEUTICS INC (DNLI:NASDAQ)?
The most recent average sentiment score for DENALI THERAPEUTICS INC (DNLI:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for DENALI THERAPEUTICS INC (DNLI:NASDAQ)?
The most recent sentiment for DENALI THERAPEUTICS INC (DNLI:NASDAQ) is .
SEC-8K** Filing Available For DENALI THERAPEUTICS INC (DNLI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.